Financial Guidance and Company Overview
95
Halozyme
(in Millions)
TRT Market is Large and Growing
10
9
2021 TRT TRX
8.0M
8
7
2021 TRT INJECTABLE TRX
6
5.9M
5
4
3
2021 TRT TRX
2
1.8M
1
1H 2016
2H 2016
1H 2017
Antares Corporate Presentation March 2022
2H 2017
1H 2018
2H 2018
1H 2019
2H 2019
XYOSTED
R
Cornerstone of the Antares Commercial Portfolio
40000
2021 TRT INJECTABLE GROWTH
5.4%
20000
80000
2021 TRT GROWTH
NRx Refills
5.1%
60000
1Q2019
2Q2019
3Q2019
4Q2019
XYOSTED ā Quarterly TrX Growth
2021 TRT TOPICAL GROWTH
1H 2020
2H 2020
1H 2021
0%
2H 2021
.
ā¢
Innovative self-delivery of testosterone replacement therapy (TRT) for at-home use
Once-a-week dosing
Virtually painless subcutaneous injection using Antares auto injector technology
-75% of all commercial lives covered
18 Orange Book listed patents extending to 2038
FY 2021 revenue of $62.2M, up 34% year-over-year
13
1Q2020
2Q2020
3Q2020
4Q2020
1Q2021
2Q2021
3Q2021
4Q2021View entire presentation